Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir/Ledipasvir in HCV/HIV-1 Coinfection
NCT02480387Phase 2Completed
- Sponsor
- Peter J. Ruane, M.D.
- Start
- May 2015
- Primary completion
- Nov 2015
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Harvoni in hepatitis C (HCV), sponsored by Peter J. Ruane, M.D.. Started May 2015; status: completed.
02
Drugs
Harvoni
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02480387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480387.